Reperfusion therapy—What's with the obstructed, leaky and broken capillaries?

Pathophysiology

Volumn 24, Issue 4, 2017, Pages 213-228

  Granger, D Neil ^a   Kvietys, Peter R ^b  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b ALFAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

Hemorrhage; Matrix metalloproteinases; Microvascular dysfunction; No reflow; Reactive oxygen species

Indexed keywords

MATRIX METALLOPROTEINASE; REACTIVE OXYGEN METABOLITE; TISSUE PLASMINOGEN ACTIVATOR;

ANGIOGENESIS; BLEEDING; BLOOD VESSEL OCCLUSION; BRAIN ISCHEMIA; CAPILLARY FLOW; CAPILLARY LEAK SYNDROME; CELL DAMAGE; CLINICAL OUTCOME; DISEASE SEVERITY; EXPERIMENTAL STUDY; HEART INFARCTION; HUMAN; ISCHEMIA; MICROANGIOPATHY; MOLECULAR PATHOLOGY; NO REFLOW PHENOMENON; NONHUMAN; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; PROTEIN INTERACTION; REPERFUSION; REPERFUSION INJURY; REPERFUSION THERAPY; REVIEW; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THERAPY; TISSUE INJURY; VASCULAR ENDOTHELIAL CELL;

EID: 85033495929     PISSN: 09284680     EISSN: 1873149X     Source Type: Journal    
DOI: 10.1016/j.pathophys.2017.09.003     Document Type: Review

References (223)

1. Heusch, G., Libby, P., Gersh, B., Yellon, D., Bohm, M., Lopaschuk, G., Opie, L., Cardiovascular remodelling in coronary artery disease and heart failure. Lancet 383 (2014), 1933–1943.
2. Ovbiagele, B., Goldstein, L.B., Higashida, R.T., Howard, V.J., Johnston, S.C., Khavjou, O.A., Lackland, D.T., Lichtman, J.H., Mohl, S., Sacco, R.L., Saver, J.L., Trogdon, J.G., American Heart Association Advocacy Coordinating Committee and Stroke Council. Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association. Stroke 44 (2013), 2361–2375.
3. Bai, J., Lyden, P.D., Revisiting cerebral postischemic reperfusion injury: new insights in understanding reperfusion failure, hemorrhage, and edema. Int. J. Stroke 10 (2015), 143–152.
4. Ibanez, B., Heusch, G., Ovize, M., Van de Werf, F., Evolving therapies for myocardial ischemia/reperfusion injury. J. Am. Coll. Cardiol. 65 (2015), 1454–1471.
5. Carden, D.L., Granger, D.N., Pathophysiology of ischaemia-reperfusion injury. J. Pathol. 190 (2000), 255–266.
6. Eltzschig, H.K., Eckle, T., Ischemia and reperfusion—from mechanism to translation. Nat. Med. 17 (2011), 1391–1401.
7. Nour, M., Scalzo, F., Liebeskind, D.S., Ischemia-reperfusion injury in stroke. Interv. Neurol. 18 (2013), 5–99.
8. Hausenloy, D.J., Yellon, D.M., Ischaemic conditioning and reperfusion injury. Nat. Rev. Cardiol. 13 (2016), 193–209.
9. Granger, D.N., Kvietys, P.R., Reperfusion injury and reactive oxygen species: the evolution of a concept. Redox Biol. 6 (2015), 524–551.
10. Fordyce, C.B., Gersh, B.J., Stone, G.W., Granger, C.B., Novel therapeutics in myocardial infarction: targeting microvascular dysfunction and reperfusion injury. Trends Pharmacol. Sci. 36 (2015), 605–616.
11. Gursoy-Ozdemir, Y., Yemisci, M., Dalkara, T., Microvascular protection is essential for successful neuroprotection in stroke. J. Neurochem. 123:Suppl. 2 (2012), 2–11.
12. Dalkara, T., Alarcon-Martinez, Cerebral microvascular pericytes and neurogliovascular signaling in health and disease. Brain Res. 1623 (2015), 3–17.
13. Butler, M.J., Chan, W., Taylor, A.J., Dart, A.M., Duffy, S.J., Management of the no-reflow phenomenon. Pharmacol. Ther. 132 (2011), 72–85.
14. Schwartz, B.G., Kloner, R.A., Coronary no reflow. J. Mol. Cell. Cardiol. 52:4 (2012), 873–882.
15. Bekkers, S.C., Yazdani, S.K., Virmani, R., Waltenberger, J., Microvascular obstruction: underlying pathophysiology and clinical diagnosis. J. Am. Coll. Cardiol. 55 (2010), 1649–1660.
16. Zhang, C., Xu, X., Potter, B.J., Wang, W., Kuo, L., Michael, L., Bagby, G.J., Chilian, W.M., TNF-alpha contributes to endothelial dysfunction in ischemia/reperfusion injury. Arterioscler. Thromb. Vasc. Biol. 26:3 (2006), 475–480.
17. Tang, Y.H., Vital, S., Russell, J., Seifert, H., Senchenkova, E., Granger, D.N., Transient ischemia elicits a sustained enhancement of thrombus development in the cerebral microvasculature: effects of anti-thrombotic therapy. Exp. Neurol. 261 (2014), 417–423.
18. Krug, A., Du Mesnil de Rochemont, Korb, G., Blood supply of the myocardium after temporary coronary occlusion. Circ. Res. 19 (1966), 57–62.
19. Kloner, R.A., Ganote, C.E., Jennings, R.B., The no-reflow phenomenon after temporary coronary occlusion in the dog. J. Clin. Invest. 54 (1974), 1496–1508.
20. Granger, D.N., Rutili, G., McCord, J.M., Superoxide radicals in feline intestinal ischemia. Gastroenterology 81 (1981), 22–29.
21. Ambrosio, G., Weisman, H.F., Mannisi, J.A., Becker, L.C., Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation 80:6 (1989), 1846–1861.
22. Kurose, I., Anderson, D.C., Miyasaka, M., Tamatani, T., Paulson, J.C., Todd, R.F., Rusche, J.R., Granger, D.N., Molecular determinants of reperfusion-induced leukocyte adhesion and vascular protein leakage. Circ. Res. 74 (1994), 336–343.
23. Ma, X.L., Lefer, D.J., Lefer, A.M., Rothlein, R., Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion. Circulation 86 (1992), 937–946.
24. Kalogeris, T., Baines, C.P., Krenz, M., Korthuis, R.J., Cell biology of ischemia/reperfusion injury. Int. Rev. Cell Mol. Biol. 298 (2012), 229–317.
25. Kurose, I., Wolf, R., Grisham, M.B., Granger, D.N., Modulation of ischemia/reperfusion-induced microvascular dysfunction by nitric oxide. Circ. Res. 74 (1994), 376–382.
26. Kurose, I., Argenbright, L.W., Wolf, R., Lianxi, L., Granger, D.N., Ischemia/reperfusion-induced microvascular dysfunction: role of oxidants and lipid mediators. Am. J. Physiol.-Heart Circ. Physiol. 272 (1997), H2976–H2982.
27. Lefer, A.M., Siegfried, M.R., Ma, X.L., Protection of ischemia-reperfusion injury by sydnonimine NO donors via inhibition of neutrophil-endothelium interaction. J. Cardiovasc. Pharmacol., 22(Suppl. 7), 1993 (S27-S23).
28. Betgem, R.P., de Waard, G.A., Nijveldt, R., Beek, A.M., Escaned, J., van Royen, N., Intramyocardial haemorrhage after acute myocardial infarction. Nat. Rev. Cardiol. 12 (2015), 156–167.
29. Zhang, J., Yang, Y., Sun, H., Xing, Y., Hemorrhagic transformation after cerebral infarction: current concepts and challenges. Ann. Transl. Med., 2, 2014, 81.
30. Bai, J., Lyden, P.D., Revisiting cerebral postischemic reperfusion injury: new insights in understanding reperfusion failure, hemorrhage, and edema. Int. J. Stroke 10 (2015), 143–152.
31. Cerra, F.B., Lajos, T.Z., Montes, M., Siegel, J.H., Structural-functional correlates of reversible myocardial anoxia. J. Surg. Res. 16 (1974), 140–152.
32. Cerra, F.B., Lajos, T.Z., Montes, M., Siegel, J.H., Hemorrhagic infarction: a reperfusion injury following prolonged myocardial ischemic anoxia. Surgery 78 (1975), 95–104.
33. Capone, R.J., Most, A.S., Myocardial hemorrhage after coronary reperfusion in pigs. Am. J. Cardiol. 41 (1978), 259–266.
34. McDonagh, P.F., The role of the coronary microcirculation in myocardial recovery from ischemia. Yale J. Biol. Med. 56 (1983), 303–311.
35. Mullane, K.M., Read, N., Salmon, J.A., Moncada, S., Role of leukocytes in acute myocardial infarction in anesthetized dogs: relationship to myocardial salvage by anti-inflammatory drugs. J. Pharmacol. Exp. Ther. 228 (1984), 510–522.
36. Fishbein, M.C., Rit, J.Y., Lando, U., Kanmatsuse, K., Mercier, J.C., Ganz, W., The relationship of vascular injury and myocardial hemorrhage to necrosis after reperfusion. Circulation 62 (1980), 1274–1279.
37. Meneely, G.R., The capillary factor in myocardial infarction. Am. J. Cardiol. 34 (1974), 583–587.
38. Higginson, L.A., White, F., Heggtveit, H.A., Sanders, T.M., Bloor, C.M., Covell, J.W., Determinants of myocardial hemorrhage after coronary reperfusion in the anesthetized dog. Circulation 65 (1982), 62–69.
39. Kamijyo, Y., Garcia, J.H., Cooper, J., Temporary regional cerebral ischemia in the cat. A model of hemorrhagic and subcortical infarction. J. Neuropathol. Exp. Neurol. 36 (1977), 338–350.
40. Ito, U., Ohno, K., Nakamura, R., Suganuma, F., Inaba, Y., Brain edema during ischemia and after restoration of blood flow. Measurement of water, sodium, potassium content and plasma protein permeability. Stroke 10 (1979), 542–547.
41. Weinstein, P.R., Anderson, G.G., Telles, D.A., Neurological deficit and cerebral infarction after temporary middle cerebral artery occlusion in unanesthetized cats. Stroke 17 (1986), 318–324.
42. Jickling, G.C., Liu, D., Stamova, B., Ander, B.P., Zhan, X., Lu, A., et al. Hemorrhagic transformation after ischemic stroke in animals and humans. J. Cereb. Blood Flow Metab. 34 (2014), 185–199.
43. Czarnowska, E., Karwatowska-Prokopczuk, E., Ultrastructural demonstration of endothelial glycocalyx disruption in the reperfused rat heart. Involvement of oxygen free radicals. Basic Res. Cardiol. 90 (1995), 357–364.
44. Kvietys, P.R., Granger, D.N., Role of reactive oxygen and nitrogen species in the vascular responses to inflammation. Free Radic. Biol. Med. 52 (2012), 556–592.
45. Rubio-Gayosso, I., Platts, S.H., Duling, B.R., Reactive oxygen species mediate modification of glycocalyx during ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 290 (2006), H2247–56.
46. van Golen, R.F., van Gulik, T.M., Heger, M., Mechanistic overview of reactive species-induced degradation of the endothelial glycocalyx during hepatic ischemia/reperfusion injury. Free Radic. Biol. Med. 52 (2012), 1382–1402.
47. Kolarova, H., Ambruzova, B., Svihalkova Sindlerova, L., Klinke, A., Kubala, L., Modulation of endothelial glycocalyx structure under inflammatory conditions. Mediat. Inflamm., 2014, 2014, 694312.
48. Nguyen, M., Arkell, J., Jackson, C.J., Human endothelial gelatinases and angiogenesis. Int. J. Biochem. Cell Biol. 33 (2001), 960–970.
49. Tong, N., Zhang, Z., Zhang, W., Qiu, Y., Gong, Y., Yin, L., Qiu, Q., Wu, X., Diosmin alleviates retinal edema by protecting the blood-retinal barrier and reducing retinal vascular permeability during ischemia/reperfusion injury. PLoS One, 8, 2013, e61794.
50. Li, Z., Jin, Z.Q., Ischemic preconditioning enhances integrity of coronary endothelial tight junctions. Biochem. Biophys. Res. Commun. 425 (2012), 630–635.
51. Deem, T.L., Cook-Mills, J.M., Vascular cell adhesion molecule 1 (VCAM-1) activation of endothelial cell matrix metalloproteinases: role of reactive oxygen species. Blood 104:8 (2004), 2385–2393.
52. Lipowsky, H.H., Lescanic, A., The effect of doxycycline on shedding of the glycocalyx due to reactive oxygen species. Microvasc. Res. 90 (2013), 80–85.
53. Reynolds, J.M., McDonagh, P.F., Platelets do not modulate leukocyte-mediated coronary microvascular damage during early reperfusion. Am. J. Physiol. 266 (1994), H171–81.
54. Kvietys, P.R., Granger, D.N., Endothelial cell monolayers as a tool for studying microvascular pathophysiology. Am. J. Physiol. 273 (1997), G1189–99.
55. Zehendner, C.M., Librizzi, L., Hedrich, J., Bauer, N.M., Angamo, E.A., de Curtis, M., Luhmann, H.J., Moderate hypoxia followed by reoxygenation results in blood-brain barrier breakdown via oxidative stress-dependent tight-junction protein disruption. PLoS One, 8, 2013, e82823.
56. Gursoy-Ozdemir, Y., Can, A., Dalkara, T., Reperfusion-induced oxidative/nitrative injury to neurovascular unit after focal cerebral ischemia. Stroke 35 (2004), 1449–1453.
57. Victorino, G.P., Ramirez, R.M., Chong, T.J., Curran, B., Sadjadi, J., Ischemia-reperfusion injury in rats affects hydraulic conductivity in two phases that are temporally and mechanistically separate. Am. J. Physiol. Heart Circ. Physiol. 295 (2008), H2164–71.
58. Schafer, C., Walther, S., Schafer, M., Dieterich, L., Kasseckert, S., Abdallah, Y., Piper, H.M., Inhibition of contractile activation reduces reoxygenation-induced endothelial gap formation. Cardiovasc. Res. 58 (2003), 149–155.
59. Gibson, C.L., Srivastava, K., Sprigg, N., Bath, P.M., Bayraktutan, U., Inhibition of Rho-kinase protects cerebral barrier from ischaemia-evoked injury through modulations of endothelial cell oxidative stress and tight junctions. J. Neurochem. 129 (2014), 816–826.
60. Fert-Bober, J., Leon, H., Sawicka, J., Basran, R.S., Devon, R.M., Schulz, R., et al. Inhibiting matrix metalloproteinase-2 reduces protein release into coronary effluent from isolated rat hearts during ischemia-reperfusion. Basic Res. Cardiol. 103:5 (2008), 431–443.
61. Granger, D.N., Holm, L., Kvietys, P., The gastrointestinal circulation: physiology and pathophysiology. Compr. Physiol. 5 (2015), 1541–1583.
62. Lerchenberger, M., Uhl, B., Stark, K., Zuchtriegel, G., Eckart, A., Miller, M., Puhr-Westerheide, D., Praetner, M., Rehberg, M., Khandoga, A.G., Lauber, K., Massberg, S., Krombach, F., Reichel, C.A., Matrix metalloproteinases modulate ameboid-like migration of neutrophils through inflamed interstitial tissue. Blood 122 (2013), 770–780.
63. Yang, Z., Sharma, A.K., Marshall, M., Kron, I.L., Laubach, V.E., NADPH oxidase in bone marrow-derived cells mediates pulmonary ischemia-reperfusion injury. Am. J. Respir. Cell Mol. Biol. 40 (2009), 375–381.
64. Fernandez-Jimenez, R., Garcia-Prieto, J., Sanchez-Gonzalez, J., Aguero, J., Lopez-Martin, G.J., Galan-Arriola, C., et al. Pathophysiology underlying the bimodal edema phenomenon after myocardial ischemia/reperfusion. J. Am. Coll. Cardiol. 66 (2015), 816–828.
65. Yang, Y., Rosenberg, G.A., Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke 42 (2011), 3323–3328.
66. Belayev, L., Busto, R., Zhao, W., Ginsberg, M.D., Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats. Brain Res. 739 (1996), 88–96.
67. Fernandez-Jimenez, R., Sanchez-Gonzalez, J., Aguero, J., Garcia-Prieto, J., Lopez-Martin, G.J., Garcia-Ruiz, J.M., et al. Myocardial edema after ischemia/reperfusion is not stable and follows a bimodal pattern: imaging and histological tissue characterization. J. Am. Coll. Cardiol. 65 (2015), 315–323.
68. Carrick, D., Haig, C., Ahmed, N., Rauhalammi, S., Clerfond, G., Carberry, J., et al. Temporal evolution of myocardial hemorrhage and edema in patients after acute ST-segment elevation myocardial infarction: pathophysiological insights and clinical implications. J. Am. Heart Assoc., 5(2), 2016.
69. Strbian, D., Durukan, A., Pitkonen, M., Marinkovic, I., Tatlisumak, E., Pedrono, E., et al. The blood-brain barrier is continuously open for several weeks following transient focal cerebral ischemia. Neuroscience 153 (2008), 175–181.
70. Shi, Y., Zhang, L., Pu, H., Mao, L., Hu, X., Jiang, X., et al. Rapid endothelial cytoskeletal reorganization enables early blood-brain barrier disruption and long-term ischaemic reperfusion brain injury. Nat. Commun., 7, 2016, 10523.
71. Chen, Y., Lui, V.C., Rooijen, N.V., Tam, P.K., Depletion of intestinal resident macrophages prevents ischaemia reperfusion injury in gut. Gut 53 (2004), 1772–1780.
72. McKittrick, C.M., Lawrence, C.E., Carswell, H.V., Mast cells promote blood brain barrier breakdown and neutrophil infiltration in a mouse model of focal cerebral ischemia. J. Cereb. Blood Flow Metab. 35 (2015), 638–647.
73. Annecke, T., Fischer, J., Hartmann, H., Tschoep, J., Rehm, M., Conzen, P., Sommerhoff, C.P., Becker, B.F., Shedding of the coronary endothelial glycocalyx: effects of hypoxia/reoxygenation vs ischemia/reperfusion. Br. J. Anaesth. 107 (2011), 679–686.
74. Hase, Y., Okamoto, Y., Fujita, Y., Kitamura, A., Nakabayashi, H., Ito, H., et al. Cilostazol, a phosphodiesterase inhibitor, prevents no-reflow and hemorrhage in mice with focal cerebral ischemia. Exp. Neurol. 233:1 (2012), 523–533.
75. Nishimura, A., Ago, T., Kuroda, J., Arimura, K., Tachibana, M., Nakamura, K., et al. Detrimental role of pericyte Nox4 in the acute phase of brain ischemia. J. Cereb. Blood Flow Metab. 36:6 (2016), 1143–1154.
76. Shi, Y., Zhang, L., Pu, H., Mao, L., Hu, X., Jiang, X., Xu, N., Stetler, R.A., Zhang, F., Liu, X., Leak, R.K., Keep, R.F., Ji, X., Chen, J., Rapid endothelial cytoskeletal reorganization enables early blood-brain barrier disruption and long-term ischaemic reperfusion brain injury. Nat. Commun., 7, 2016, 10523.
77. Adamson, R.H., Zeng, M., Adamson, G.N., Lenz, J.F., Curry, F.E., PAF- and bradykinin-induced hyperpermeability of rat venules is independent of actin-myosin contraction. Am. J. Physiol. Heart Circ. Physiol. 285 (2003), H406–17.
78. Knezevic, I.I., Predescu, S.A., Neamu, R.F., Gorovoy, M.S., Knezevic, N.M., Easington, C., Malik, A.B., Predescu, D.N., Tiam1 and Rac1 are required for platelet-activating factor-induced endothelial junctional disassembly and increase in vascular permeability. J. Biol. Chem. 284 (2009), 5381–5394.
79. Inauen, W., Granger, D.N., Meininger, C.J., Schelling, M.E., Granger, H.J., Kvietys, P.R., Anoxia-reoxygenation-induced, neutrophil-mediated endothelial cell injury: role of elastase. Am. J. Physiol. 259 (1990), H925–31.
80. Yoshida, N., Cepinskas, G., Granger, D.N., Anderson, D.C., Wolf, R.E., Kvietys, P.R., Aspirin-induced, neutrophil-mediated injury to vascular endothelium. Inflammation 19 (1995), 297–312.
81. Gupta, A.K., Joshi, M.B., Philippova, M., Erne, P., Hasler, P., Hahn, S., Resink, T.J., Activated endothelial cells induce neutrophil extracellular traps and are susceptible to NETosis-mediated cell death. FEBS Lett. 584 (2010), 3193–3197.
82. Savchenko, A.S., Borissoff, J.I., Martinod, K., De Meyer, S.F., Gallant, M., Erpenbeck, L., Brill, A., Wang, Y., Wagner, D.D., VWF-mediated leukocyte recruitment with chromatin decondensation by PAD4 increases myocardial ischemia/reperfusion injury in mice. Blood 123 (2014), 141–148.
83. Tarikuz Zaman, A.K., Spees, J.L., Sobel, B.E., Attenuation of cardiac vascular rhexis: a promising therapeutic target. Coron. Artery Dis. 24 (2013), 245–252.
84. Zaman, A.K., French, C.J., Spees, J.L., Binbrek, A.S., Sobel, B.E., Vascular rhexis in mice subjected to non-sustained myocardial ischemia and its therapeutic implications. Exp. Biol. Med. (Maywood) 236 (2011), 598–603.
85. Krueger, M., Bechmann, I., Immig, K., Reichenbach, A., Hartig, W., Michalski, D., Blood-brain barrier breakdown involves four distinct stages of vascular damage in various models of experimental focal cerebral ischemia. J. Cereb. Blood Flow Metab. 35 (2015), 292–303.
86. Del Zoppo, G.J., Saver, J.L., Jauch, E.C., Adams, H.P. Jr., American Heart Association Stroke C, Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke 40 (2009), 2945–2948.
87. Turner, R.J., Sharp, F.R., Implications of MMP9 for blood brain barrier disruption and hemorrhagic transformation following ischemic stroke. Front. Cell. Neurosci., 10, 2016, 56.
88. Suzuki, Y., Nagai, N., Umemura, K., A review of the mechanisms of blood-brain barrier permeability by tissue-type plasminogen activator treatment for cerebral ischemia. Front. Cell. Neurosci., 10, 2016, 2.
89. Hiu, T., Nakagawa, S., Hayashi, K., Kitagawa, N., Tsutsumi, K., Kawakubo, J., Honda, M., Suyama, K., Nagata, I., Niwa, M., Tissue plasminogen activator enhances the hypoxia/reoxygenation-induced impairment of the blood-brain barrier in a primary culture of rat brain endothelial cells. Cell. Mol. Neurobiol. 28 (2008), 1139–1146.
90. Song, H., Cheng, Y., Bi, G., Zhu, Y., Jun, W., Ma, W., Wu, H., Release of matrix metalloproteinases-2 and 9 by S-nitrosylated caveolin-1 contributes to degradation of extracellular matrix in tPA-treated hypoxic endothelial cells. PLoS One, 11, 2016, e0149269.
91. Uhl, B., Zuchtriegel, G., Puhr-Westerheide, D., Praetner, M., Rehberg, M., Fabritius, M., Hessenauer, M., Holzer, M., Khandoga, A., Furst, R., Zahler, S., Krombach, F., Reichel, C.A., Tissue plasminogen activator promotes postischemic neutrophil recruitment via its proteolytic and nonproteolytic properties. Arterioscler. Thromb. Vasc. Biol. 34 (2014), 1495–1504.
92. Strbian, D., Karjalainen-Lindsberg, M.L., Kovanen, P.T., Tatlisumak, T., Lindsberg, P.J., Mast cell stabilization reduces hemorrhage formation and mortality after administration of thrombolytics in experimental ischemic stroke. Circulation 116 (2007), 411–418.
93. Asahi, M., Asahi, K., Wang, X., Lo, E.H., Reduction of tissue plasminogen activator-induced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 20 (2000), 452–457.
94. Chen, H.S., Chen, X.M., Feng, J.H., Liu, K.J., Qi, S.H., Shen, J.G., Peroxynitrite decomposition catalyst reduces delayed thrombolysis-induced hemorrhagic transformation in ischemia-reperfused rat brains. CNS Neurosci. Ther. 21 (2015), 585–590.
95. Lanzer, P., Widimsky, P., Ischaemic stroke and ST-segment elevation myocardial infarction: fast-track single-stop approach. Eur. Heart J. 36:35 (2015), 2348–2355.
96. Wang, W., Li, M., Chen, Q., Wang, J., Hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke: mechanisms, models, and biomarkers. Mol. Neurobiol. 52:3 (2015), 1572–1579.
97. Ames, A., Wright, R.L., Kowada, M., Thurston, J.M., Majno, G., Cerebral ischemia. II. The no-reflow phenomenon. Am. J. Pathol. 52 (1968), 437–453.
98. Engler, R.L., Schmid-Schönbein, G.W., Pavelec, R.S., Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. Am. J. Pathol. 111 (1983), 98–111.
99. Schmid-Schönbein, G.W., Capillary plugging by granulocytes and the no-reflow phenomenon in the microcirculation. Fed. Proc. 46:7 (1987), 2397–2401.
100. Jerome, S.N., Akimitsu, T., Korthuis, R.J., Leukocyte adhesion, edema, and development of postischemic capillary no-reflow. Am. J. Physiol. 267 (1994), H1329–H1336.
101. Czarnowska, E., Karwatowska-Prokopczuk, E., Ultrastructural demonstration of endothelial glycocalyx disruption in the reperfused rat heart: involvement of oxygen free radicals. Basic Res. Cardiol. 90 (1995), 357–364.
102. Jerome, S.N., Smith, C.W., Korthuis, R.J., CD18-dependent adherence reactions play an important role in the development of the no-reflow phenomenon. Am. J. Physiol. 264 (1993), H479–83.
103. Reffelmann, T., Kloner, R.A., The no-reflow phenomenon: basic science and clinical correlates. Heart 87:2 (2002), 162–168.
104. Horie, Y., Wolf, R., Miyasaka, M., Anderson, D.C., Granger, D.N., Leukocyte adhesion and hepatic microvascular responses to intestinal ischemia/reperfusion in rats. Gastroenterology 111:3 (1996), 666–673.
105. Mori, E., del Zoppo, G.J., Chambers, J.D., Copeland, B.R., Arfors, K.E., Inhibition of polymorphonuclear leukocyte adherence suppresses no-reflow after focal cerebral ischemia in baboons. Stroke, 1992, 712–718.
106. Choudhri, T.F., Hoh, B.L., Zerwes, H.G., Prestigiacomo, C.J., Kim, S.C., Connolly, E.S. Jr., Kottirsch, G., Pinsky, D.J., Reduced microvascular thrombosis and improved outcome in acute murine stroke by inhibiting GP IIb/IIIa receptor-mediated platelet aggregation. J. Clin. Invest. 102 (1998), 1301–1310.
107. Golino, P., Maroko, P.R., Carew, T.E., Efficacy of platelet depletion in counteracting the detrimental effect of acute hypercholesterolemia on infarct size and the no-reflow phenomenon in rabbits undergoing coronary artery occlusion-reperfusion. Circulation 76 (1987), 173–180.
108. Golino, P., Ragni, M., Cirillo, P., Avvedimento, V.E., Feliciello, A., Esposito, N., Scognamiglio, A., Trimarco, B., Iaccarino, G., Condorelli, M., Chiariello, M., Ambrosio, G., Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion. Nat. Med. 2 (1996), 35–40.
109. Wu, K.C., CMR of microvascular obstruction and hemorrhage in myocardial infarction. J. Cardiovasc. Magn. Reson., 14, 2012, 68.
110. House, S., Lipowsky, H., Leukocyte-endothelium adhesion: microhemodynamics in mesentery of the cat. Microvasc. Res. 34 (1987), 363–379.
111. Mokhtarudin, M.J., Payne, S.J., Mathematical model of the effect of ischemia-reperfusion on brain capillary collapse and tissue swelling. Math. Biosci. 263 (2015), 111–120.
112. Manciet, L.H., Poole, D.C., McDonagh, P.F., Mathieu, J.G., Microvascular compression during myocardial ischemia: mechanistic basis for no-reflow phenomenon. Am. J. Physiol. 266 (1994), H1541–50.
113. Little, J.R., Kerr, F.W., Sundt, T.M. Jr., Microcirculatory obstruction in focal cerebral ischemia: relationship to neuronal alterations. Mayo Clin. Proc. 50 (1975), 264–270.
114. Garcia, J.H., Liu, K.F., Yoshida, Y., Chen, S., Lian, J., Brain microvessels: factors altering their patency after the occlusion of a middle cerebral artery (Wistar rat). Am. J. Pathol. 145 (1994), 728–740.
115. Kidambi, A., Mather, A.N., Motwani, M., Swoboda, P., Uddin, A., Greenwood, J.P., Plein, S., The effect of microvascular obstruction and intramyocardial hemorrhage on contractile recovery in reperfused myocardial infarction: insights from cardiovascular magnetic resonance. J. Cardiovasc. Magn. Reson., 15, 2013, 58.
116. Kandler, D., Lücke, C., Grothoff, M., Andres, C., Lehmkuhl, L., Nitzsche, S., Riese, F., Mende, M., de Waha, S., Desch, S., Lurz, P., Eitel, I., Gutberlet, M., The relation between hypointense core, microvascular obstruction and intramyocardial haemorrhage in acute reperfused myocardial infarction assessed by cardiac magnetic resonance imaging. Eur. Radiol. 24:12 (2014), 3277–3288.
117. VanBenthuysen, K.M., McMurtry, I.F., Horwitz, L.D., Reperfusion after acute coronary occlusion in dogs impairs endothelium-dependent relaxation to acetylcholine and augments contractile reactivity in vitro. J. Clin. Invest. 79 (1987), 265–274.
118. Quillen, J.E., Sellke, F.W., Brooks, L.A., Harrison, D.G., Ischemia-reperfusion impairs endothelium-dependent relaxation of coronary microvessels but does not affect large arteries. Circulation 82 (1990), 586–594.
119. Gao, X., Zhang, H., Belmadani, S., Wu, J., Xu, X., Elford, H., Potter, B.J., Zhang, C., Role of TNF-alpha-induced reactive oxygen species in endothelial dysfunction during reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 295 (2008), H2242–9.
120. Malliani, A., Schwartz, P.J., Zanchetti, A., A sympathetic reflex elicited by experimental coronary occlusion. Am. J. Physiol., 217, 1969, 703.
121. Shimizu, M., Wang, Q., Sjoquist, P.O., Ryden, L., Effects of the angiotensin AT1-receptor antagonist candesartan improves recovery and reduced no-reflow area in reperfused ischemic hearts. J. Cardiovasc. Pharmacol., 34, 1999, 78.
122. Ryckwaert, F., Colson, P., Guillon, C., Foex, P., Cumulative effects of AT1 and AT2 receptor blockade on ischemia-reperfusion recovery in rat hearts. Pharmacol. Res. 51 (2005), 497–502.
123. Yemisci, M., Gursoy-Ozdemir, Y., Vural, A., Can, A., Topalkara, K., Dalkara, T., Pericyte contraction induced by oxidative stress impairs capillary reflow despite successful opening of occluded cerebral artery. Nat. Med. 15 (2009), 1031–1037.
124. Dalkara, T., Arsava, E.M., Can restoring incomplete microcirculatory reperfusion improve stroke outcome after thrombolysis. J. Cereb. Blood Flow Metab. 32 (2012), 2091–2099.
125. Bekkers, S.C., Smulders, M.W., Passos, V.L., Leiner, T., Waltenberger, J., Gorgels, A.P., Schalla, S., Clinical implications of microvascular obstruction and intramyocardial haemorrhage in acute myocardial infarction using cardiovascular magnetic resonance imaging. Eur. Radiol. 20 (2010), 2572–2578.
126. Mathey, D.G., Schofer, J., Kuck, K.H., Beil, U., Klöppel, G., Transmural, haemorrhagic myocardial infarction after intracoronary streptokinase. Clinical, angiographic, and necropsy findings. Br. Heart J. 48 (1982), 546–551.
127. Bouleti, C., Mewton, N., Germain, S., The no-reflow phenomenon: state of the art. Arch. Cardiovasc. Dis. 108 (2015), 661–674.
128. Zhao, H., Lee, A.P., Li, Z., Qiao, Z., Fan, Y., An, D., Xu, J., Pu, J., Shen, X., Ge, H., He, B., Impact of Intramyocardial hemorrhage and microvascular obstruction on cardiac mechanics in reperfusion injury: a speckle-tracking echocardiographic study. J. Am. Soc. Echocardiogr. 29 (2016), 973–982.
129. Beek, A.M., Nijveldt, R., van Rossum, A.C., Intramyocardial hemorrhage and microvascular obstruction after primary percutaneous coronary intervention. Int. J. Cardiovasc. Imaging 26 (2010), 49–55.
130. Robbers, L.F., Eerenberg, E.S., Teunissen, P.F., Jansen, M.F., Hollander, M.R., Horrevoets, A.J., et al. Magnetic resonance imaging-defined areas of microvascular obstruction after acute myocardial infarction represent microvascular destruction and haemorrhage. Eur. Heart J. 34 (2013), 2346–2353.
131. Ganame, J., Messalli, G., Dymarkowski, S., Rademakers, F.E., Desmet, W., Van de Werf, F., Bogaert, J., Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction. Eur. Heart J. 30 (2009), 1440–1449.
132. Ørn, S., Manhenke, C., Greve, O.J., Larsen, A.I., Bonarjee, V.V., Edvardsen, T., Dickstein, K., Microvascular obstruction is a major determinant of infarct healing and subsequent left ventricular remodelling following primary percutaneous coronary intervention. Eur. Heart J. 30 (2009), 1978–1985.
133. Waller, B.F., Rothbaum, D.A., Pinkerton, C.A., Cowley, M.J., Linnemeier, T.J., Orr, C., Irons, M., Helmuth, R.A., Wills, E.R., Aust, C., Status of the myocardium and infarct-related coronary artery in 19 necropsy patients with acute recanalization using pharmacologic (streptokinase, r-tissue plasminogen activator), mechanical (percutaneous transluminal coronary angioplasty) or combined types of reperfusion therapy. J. Am. Coll. Cardiol. 9 (1987), 785–801.
134. Soares, B.P., Tong, E., Hom, J., Cheng, S.C., Bredno, J., Boussel, L., Smith, W.S., Wintermark, M., Reperfusion is a more accurate predictor of follow-up infarct volume than recanalization: a proof of concept using CT in acute ischemic stroke patients. Stroke 41:1 (2010), e34–e40.
135. McCord, J.M., Oxygen-derived free radicals in postischemic tissue injury. N. Engl. J. Med. 312 (1985), 159–163.
136. Shafik, A.N., Febuxostat improves the local and remote organ changes induced by intestinal ischemia/reperfusion in rats. Dig. Dis. Sci. 58 (2013), 650–659.
137. Drose, S., Stepanova, A., Galkin, A., Ischemic A/D transition of mitochondrial complex I and its role in ROS generation. Biochim. Biophys. Acta 1857 (2016), 946–957.
138. Sanderson, T.H., Reynolds, C.A., Kumar, R., Przyklenk, K., Huttemann, M., Molecular mechanisms of ischemia-reperfusion injury in brain: pivotal role of the mitochondrial membrane potential in reactive oxygen species generation. Mol. Neurobiol. 47 (2013), 9–23.
139. Chen, Y.R., Zweier, J.L., Cardiac mitochondria and reactive oxygen species generation. Circ. Res. 114 (2014), 524–537.
140. Chouchani, E.T., Methner, C., Nadtochiy, S.M., Logan, A., Pell, V.R., Ding, S., James, A.M., Cocheme, H.M., Reinhold, J., Lilley, K.S., Partridge, L., Fearnley, I.M., Robinson, A.J., Hartley, R.C., Smith, R.A., Krieg, T., Brookes, P.S., Murphy, M.P., Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I. Nat. Med. 19 (2013), 753–759.
141. Chouchani, E.T., Pell, V.R., Gaude, E., Aksentijevic, D., Sundier, S.Y., Robb, E.L., Logan, A., Nadtochiy, S.M., Ord, E.N., Smith, A.C., Eyassu, F., Shirley, R., Hu, C.H., Dare, A.J., James, A.M., Rogatti, S., Hartley, R.C., Eaton, S., Costa, A.S., Brookes, P.S., Davidson, S.M., Duchen, M.R., Saeb-Parsy, K., Shattock, M.J., Robinson, A.J., Work, L.M., Frezza, C., Krieg, T., Murphy, M.P., Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature 515 (2014), 431–435.
142. Niatsetskaya, Z.V., Sosunov, S.A., Matsiukevich, D., Utkina-Sosunova, I.V., Ratner, V.I., Starkov, A.A., Ten, V.S., The oxygen free radicals originating from mitochondrial complex I contribute to oxidative brain injury following hypoxia-ischemia in neonatal mice. J. Neurosci. 32 (2012), 3235–3244.
143. Juhaszova, M., Zorov, D.B., Kim, S.H., Pepe, S., Fu, Q., Fishbein, K.W., Ziman, B.D., Wang, S., Ytrehus, K., Antos, C.L., Olson, E.N., Sollott, S.J., Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J. Clin. Invest. 113 (2004), 1535–1549.
144. Kleikers, P.W., Wingler, K., Hermans, J.J., Diebold, I., Altenhofer, S., Radermacher, K.A., Janssen, B., Gorlach, A., Schmidt, H.H., NADPH oxidases as a source of oxidative stress and molecular target in ischemia/reperfusion injury. J. Mol. Med. 90 (2012), 1391–1406.
145. Kahles, T., Brandes, R.P., Which NADPH oxidase isoform is relevant for ischemic stroke? The case for Nox2. Antioxid. Redox Signal. 18 (2013), 1400–1417.
146. Choi, D.H., Kim, J.H., Lee, K.H., Kim, H.Y., Kim, Y.S., Choi, W.S., Lee, J., Role of neuronal NADPH oxidase1 in the peri-infarct regions after stroke. PLoS One, 10, 2015, e0116814.
147. Doerries, C., Grote, K., Hilfiker-Kleiner, D., Luchtefeld, M., Schaefer, A., Holland, S.M., Sorrentino, S., Manes, C., Schieffer, B., Drexler, S., Landmesser, H.U., Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction. Circ. Res. 100 (2007), 894–903.
148. Chen, H., Song, Y.S., Chan, P.H., Inhibition of NADPH oxidase is neuroprotective after ischemia-reperfusion. J. Cereb. Blood Flow Metab. 29 (2009), 1262–1272.
149. Braunersreuther, V., Montecucco, F., Asrih, M., Pelli, G., Galan Frias, K.M., Burger, F., Quindere, A.L., Montessuit, C., Krause, K.H., Mach, F., Jaquet, V., Role of NADPH oxidase isoforms nox1, nox2 and nox4 in myocardial ischemia/reperfusion injury. J. Mol. Cell. Cardiol. 64 (2013), 99–107.
150. Tang, X.N., Zheng, Z., Giffard, R.G., Yenari, M.A., Significance of marrow-derived nicotinamide adenine dinucleotide phosphate oxidase in experimental ischemic stroke. Ann. Neurol. 70 (2011), 606–615.
151. Kleinschnitz, C., Grund, H., Wingler, K., Armitage, M.E., Jones, E., Mittal, M., Barit, D., Schwarz, T., Geis, C., Kraft, P., Barthel, K., Schuhmann, M.K., Herrmann, A.M., Meuth, S.G., Stoll, G., Meurer, S., Schrewe, A., Becker, L., Gailus-Durner, V., Fuchs, H., Klopstock, T., deAngelis, M.H., Jandeleit-Dahm, K., Shah, A.M., Weissmann, N., Schmidt, H.H., Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration. PLoS Biol., 8(9), 2010, e1000479.
152. Forstermann, U., Sessa, W.C., Nitric oxide synthases: regulation and function. Eur. Heart J. 33 (2012), 829–837 (837a-837d).
153. Alkaitis, M.S., Crabtree, M.J., Recoupling the cardiac nitric oxide synthases: tetrahydrobiopterin synthesis and recycling. Curr. Heart Fail. Rep. 9 (2012), 200–210.
154. Kietadisorn, R., Juni, R.P., Moens, A.L., Tackling endothelial dysfunction by modulating NOS uncoupling: new insights into its pathogenesis and therapeutic possibilities. Am. J. Physiol. Endocrinol. Metab. 302 (2012), E481–95.
155. Roe, N.D., Ren, J., Nitric oxide synthase uncoupling: a therapeutic target in cardiovascular diseases. Vascul. Pharmacol. 57 (2012), 168–172.
156. De Pascali, F., Hemann, C., Samons, K., Chen, C.A., Zweier, J.L., Hypoxia and reoxygenation induce endothelial nitric oxide synthase uncoupling in endothelial cells through tetrahydrobiopterin depletion and S-glutathionylation. Biochemistry 53 (2014), 3679–3688.
157. Dumitrescu, C., Biondi, R., Xia, Y., Cardounel, A.J., Druhan, L.J., Ambrosio, G., Zweier, J.L., Myocardial ischemia results in tetrahydrobiopterin (BH4) oxidation with impaired endothelial function ameliorated by BH4. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 15081–15086.
158. Siu, K.L., Lotz, C., Ping, P., Cai, H., Netrin-1 abrogates ischemia/reperfusion-induced cardiac mitochondrial dysfunction via nitric oxide-dependent attenuation of NOX4 activation and recoupling of NOS. J. Mol. Cell. Cardiol. 78 (2015), 174–185.
159. King, A.L., Polhemus, D.J., Bhushan, S., Otsuka, H., Kondo, K., Nicholson, C.K., Bradley, J.M., Islam, K.N., Calvert, J.W., Tao, Y.X., Dugas, T.R., Kelley, E.E., Elrod, J.W., Huang, P.L., Wang, R., Lefer, D.J., Hydrogen sulfide cytoprotective signaling is endothelial nitric oxide synthase-nitric oxide dependent. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), 3182–3187.
160. Pernow, J., Jung, C., Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal?. Cardiovasc. Res. 98 (2013), 334–343.
161. Schreckenberg, R., Weber, P., Cabrera-Fuentes, H.A., Steinert, I., Preissner, K.T., Bencsik, P., Sarkozy, M., Csonka, C., Ferdinandy, P., Schulz, R., Schluter, K.D., Mechanism and consequences of the shift in cardiac arginine metabolism following ischaemia and reperfusion in rats. Thromb. Haemost. 113 (2015), 482–493.
162. Yang, J., Gonon, A.T., Sjoquist, P.O., Lundberg, J.O., Pernow, J., Arginase regulates red blood cell nitric oxide synthase and export of cardioprotective nitric oxide bioactivity. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 15049–15054.
163. Tratsiakovich, Y., Gonon, A.T., Kiss, A., Yang, J., Bohm, F., Tornvall, P., Settergren, M., Channon, K.M., Sjoquist, P.O., Pernow, J., Myocardial protection by co-administration of L-arginine and tetrahydrobiopterin during ischemia and reperfusion. Int. J. Cardiol. 169 (2013), 83–88.
164. Dejonckheere, E., Vandenbroucke, R.E., Libert, C., Matrix metalloproteinases as drug targets in ischemia/reperfusion injury. Drug Discov. Today 16:17–18 (2011), 762–778.
165. Nagase, H., Woessner, J.F. Jr., Matrix metalloproteinases. J. Biol. Chem. 274:31 (1999), 21491–21494.
166. Loffek, S., Schilling, O., Franzke, C.W., Series matrix metalloproteinases in lung health and disease: biological role of matrix metalloproteinases: a critical balance. Eur. Respir. J. 38:1 (2011), 191–208.
167. Parks, W.C., Wilson, C.L., Lopez-Boado, Y.S., Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat. Rev. Immunol. 4:8 (2004), 617–629.
168. Murphy, G., Nagase, H., Progress in matrix metalloproteinase research. Mol. Asp. Med. 29:5 (2008), 290–308.
169. Chelladurai, P., Seeger, W., Pullamsetti, S.S., Matrix metalloproteinases and their inhibitors in pulmonary hypertension. Eur. Respir. J. 40:3 (2012), 766–782.
170. Lenglet, S., Montecucco, F., Mach, F., Schaller, K., Gasche, Y., Copin, J.C., Analysis of the expression of nine secreted matrix metalloproteinases and their endogenous inhibitors in the brain of mice subjected to ischaemic stroke. Thromb. Haemost. 112:2 (2014), 363–378.
171. Lindsey, M.L., Zamilpa, R., Temporal and spatial expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases following myocardial infarction. Cardiovasc. Ther. 30:1 (2012), 31–41.
172. Lakhan, S.E., Kirchgessner, A., Tepper, D., Leonard, A., Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke. Front. Neurol., 4, 2013, 32.
173. Spinale, F.G., Villarreal, F., Targeting matrix metalloproteinases in heart disease: lessons from endogenous inhibitors. Biochem. Pharmacol. 90:1 (2014), 7–15.
174. Yang, Y., Rosenberg, G.A., Matrix metalloproteinases as therapeutic targets for stroke. Brain Res. 1623 (2015), 30–38.
175. Neri, M., Riezzo, I., Pascale, N., Pomara, C., Turillazzi, E., Ischemia/reperfusion injury following acute myocardial infarction: a critical issue for clinicians and forensic pathologists. Mediat. Inflamm., 2017, 2017, 7018393.
176. Lindsey, M.L., Iyer, R.P., Jung, M., DeLeon-Pennell, K.Y., Ma, Y., Matrix metalloproteinases as input and output signals for post-myocardial infarction remodeling. J. Mol. Cell. Cardiol. 91 (2016), 134–140.
177. Kim, H.Y., Han, S.H., Matrix metalloproteinases in cerebral ischemia. J. Clin. Neurol. 2:3 (2006), 163–170.
178. Sela-Passwell, N., Rosenblum, G., Shoham, T., Sagi, I., Structural and functional bases for allosteric control of MMP activities: can it pave the path for selective inhibition?. Biochim. Biophys. Acta 1 (1803), 29–38.
179. Ethell, I.M., Ethell, D.W., Matrix metalloproteinases in brain development and remodeling: synaptic functions and targets. J. Neurosci. Res. 85:13 (2007), 2813–2823.
180. Ra, H.J., Parks, W.C., Control of matrix metalloproteinase catalytic activity. Matrix Biol. 26:8 (2007), 587–596.
181. Tallant, C., Marrero, A., Gomis-Ruth, F.X., Matrix metalloproteinases: fold and function of their catalytic domains. Biochim. Biophys. Acta 1803:1 (2010), 20–28.
182. Nissinen, L., Kahari, V.M., Matrix metalloproteinases in inflammation. Biochim. Biophys. Acta 1840:8 (2014), 2571–2580.
183. Rodriguez, D., Morrison, C.J., Overall, C.M., Matrix metalloproteinases: what do they not do? New substrates and biological roles identified by murine models and proteomics. Biochim. Biophys. Acta 1803:1 (2010), 39–54.
184. Chakraborti, S., Mandal, M., Das, S., Mandal, A., Chakraborti, T., Regulation of matrix metalloproteinases: an overview. Mol. Cell. Biochem. 253:1–2 (2003), 269–285.
185. Aschner, Y., Zemans, R.L., Yamashita, C.M., Downey, G.P., Matrix metalloproteinases and protein tyrosine kinases: potential novel targets in acute lung injury and ARDS. Chest 146:4 (2014), 1081–1091.
186. Khokha, R., Murthy, A., Weiss, A., Metalloproteinases and their natural inhibitors in inflammation and immunity. Nat. Rev. Immunol. 13:9 (2013), 649–665.
187. Hayashida, K., Bartlett, A.H., Chen, Y., Park, P.W., Molecular and cellular mechanisms of ectodomain shedding. Anat. Rec. (Hoboken) 293:6 (2010), 925–937.
188. Alameddine, H.S., Morgan, J.E., Matrix metalloproteinases and tissue inhibitor of metalloproteinases in inflammation and fibrosis of skeletal muscles. J. Neuromuscul. Dis. 3:4 (2016), 455–473.
189. Yang, Y., Rosenberg, G.A., Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke 42:11 (2011), 3323–3328 (61).
190. Yamamoto, K., Murphy, G., Troeberg, L., Extracellular regulation of metalloproteinases. Matrix Biol. 44–46 (2015), 255–263.
191. Kvietys, P.R., Sandig, M., Neutrophil diapedesis: paracellular or transcellular. News Physiol. Sci. 16 (2001), 15–19.
192. Cepinskas, G., Sandig, M., Kvietys, P.R., PAF-induced elastase-dependent neutrophil transendothelial migration is associated with the mobilization of elastase to the neutrophil surface and localization to the migrating front. J. Cell Sci. 112:Pt. 12 (1999), 1937–1945.
193. Pilcher, B.K., Dumin, J.A., Sudbeck, B.D., Krane, S.M., Welgus, H.G., Parks, W.C., The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix. J. Cell Biol. 137:6 (1997), 1445–1457.
194. Arpino, V., Brock, M., Gill, S.E., The role of TIMPs in regulation of extracellular matrix proteolysis. Matrix Biol. 44–46 (2015), 247–254.
195. Alameddine, H.S., Matrix metalloproteinases in skeletal muscles: friends or foes?. Neurobiol. Dis. 48:3 (2012), 508–518.
196. Brew, K., Nagase, H., The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim. Biophys. Acta 1803:1 (2010), 55–71.
197. Jackson, H.W., Defamie, V., Waterhouse, P., Khokha, R., TIMPs: versatile extracellular regulators in cancer. Nat. Rev. Cancer 17:1 (2017), 38–53.
198. Lalu, M.M., Pasini, E., Schulze, C.J., Ferrari-Vivaldi, M., Ferrari-Vivaldi, G., Bachetti, T., et al. Ischaemia-reperfusion injury activates matrix metalloproteinases in the human heart. Eur. Heart J. 26:1 (2005), 27–35.
199. Dobaczewski, M., Gonzalez-Quesada, C., Frangogiannis, N.G., The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction. J. Mol. Cell. Cardiol. 48:3 (2010), 504–511.
200. Turner, R.J., Sharp, F.R., Implications of MMP9 for Blood brain barrier disruption and hemorrhagic transformation following ischemic stroke. Front. Cell. Neurosci., 10, 2016, 56 37. 81.
201. Hu, X., De Silva, T.M., Chen, J., Fraci, F.M., Cerebral vascular disease and neurovascular injury in ischemic stroke. Circ. Res. 120:3 (2017), 449–471.
202. Iyer, R.P., Patterson, N.L., Fields, G.B., Lindsey, M.L., The history of matrix metalloproteinases: milestones, myths, and misperceptions. Am. J. Physiol. Heart Circ. Physiol. 303:8 (2012), H919–30.
203. Alfonso-Jaume, M.A., Bergman, M.R., Mahimkar, R., Cheng, S., Jin, Z.Q., Karliner, J.S., et al. Cardiac ischemia-reperfusion injury induces matrix metalloproteinase-2 expression through the AP-1 components FosB and JunB. Am. J. Physiol. Heart Circ. Physiol. 291:4 (2006), H1838–46.
204. Nishimura, A., Ago, T., Kuroda, J., Arimura, K., Tachibana, M., Nakamura, K., et al. Detrimental role of pericyte Nox4 in the acute phase of brain ischemia. J. Cereb. Blood Flow Metab. 36:6 (2016), 1143–1154.
205. Clark, I.M., Swingler, T.E., Sampieri, C.L., Edwards, D.R., The regulation of matrix metalloproteinases and their inhibitors. Int. J. Biochem. Cell Biol. 40:6–7 (2008), 1362–1378.
206. Fujimoto, M., Takagi, Y., Aoki, T., Hayase, M., Marumo, T., Gomi, M., et al. Tissue inhibitor of metalloproteinases protect blood-brain barrier disruption in focal cerebral ischemia. J. Cereb. Blood Flow Metab. 28:10 (2008), 1674–1685.
207. Reuter, B., Rodemer, C., Grudzenski, S., Couraud, P.O., Weksler, B., Romero, I.A., et al. Temporal profile of matrix metalloproteinases and their inhibitors in a human endothelial cell culture model of cerebral ischemia. Cerebrovasc. Dis. 35:6 (2013), 514–520.
208. Takawale, A., Fan, D., Basu, R., Shen, M., Parajuli, N., Wang, W., et al. Myocardial recovery from ischemia-reperfusion is compromised in the absence of tissue inhibitor of metalloproteinase 4. Circ. Heart Fail. 7:4 (2014), 652–662.
209. Piccardi, B., Palumbo, V., Nesi, M., Nencini, P., Gori, A.M., Giusti, B., et al. Unbalanced metalloproteinase-9 and tissue inhibitors of metalloproteinases ratios predict hemorrhagic transformation of lesion in ischemic stroke patients treated with thrombolysis: results from the MAGIC study. Front. Neurol., 6, 2015, 121.
210. Spallarossa, P., Altieri, P., Garibaldi, S., Ghigliotti, G., Barisione, C., Manca, V., et al. Matrix metalloproteinase-2 and −9 are induced differently by doxorubicin in H9c2 cells: the role of MAP kinases and NAD(P)H oxidase. Cardiovasc. Res. 69:3 (2006), 736–745.
211. Singh, R.B., Hryshko, L., Freed, D., Dhalla, N.S., Activation of proteolytic enzymes and depression of the sarcolemmal Na+/K+-ATPase in ischemia-reperfused heart may be mediated through oxidative stress. Can. J. Physiol. Pharmacol. 90:2 (2012), 249–260.
212. Rakkar, K., Srivastava, K., Bayraktutan, U., Attenuation of urokinase activity during experimental ischaemia protects the cerebral barrier from damage through regulation of matrix metalloproteinase-2 and NAD(P)H oxidase. Eur. J. Neurosci. 39:12 (2014), 2119–2128.
213. Rajagopalan, S., Meng, X.P., Ramasamy, S., Harrison, D.G., Galis, Z.S., Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J. Clin. Invest. 98:11 (1996), 2572–2579.
214. Shah, S.V., Baricos, W.H., Basci, A., Degradation of human glomerular basement membrane by stimulated neutrophils. Activation of a metalloproteinase(s) by reactive oxygen metabolites. J. Clin. Invest. 79:1 (1987), 25–31.
215. Okamoto, T., Akaike, T., Sawa, T., Miyamoto, Y., van der Vliet, A., Maeda, H., Activation of matrix metalloproteinases by peroxynitrite-induced protein S-glutathiolation via disulfide S-oxide formation. J. Biol. Chem. 276:31 (2001), 29596–29602.
216. van Golen, R.F., van Gulik, T.M., Heger, M., Mechanistic overview of reactive species-induced degradation of the endothelial glycocalyx during hepatic ischemia/reperfusion injury. Free Radic. Biol. Med. 52:8 (2012), 1382–1402.
217. Grote, K., Flach, I., Luchtefeld, M., Akin, E., Holland, S.M., Drexler, H., et al. Mechanical stretch enhances mRNA expression and proenzyme release of matrix metalloproteinase-2 (MMP-2) via NAD(P)H oxidase-derived reactive oxygen species. Circ. Res. 92:11 (2003), e80–6.
218. Deem, T.L., Cook-Mills, J.M., Vascular cell adhesion molecule 1 (VCAM-1) activation of endothelial cell matrix metalloproteinases: role of reactive oxygen species. Blood 104:8 (2004), 2385–2393.
219. Weiss, S.J., Peppin, G., Ortiz, X., Ragsdale, C., Test, S.T., Oxidative autoactivation of latent collagenase by human neutrophils. Science 227:4688 (1985), 747–749.
220. Fu, X., Kassim, S.Y., Parks, W.C., Heinecke, J.W., Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase. J. Biol. Chem. 276:44 (2001), 41279–41287.
221. Shabani, F., McNeil, J., Tippett, L., The oxidative inactivation of tissue inhibitor of metalloproteinase-1 (TIMP-1) by hypochlorous acid (HOCI) is suppressed by anti-rheumatic drugs. Free Radic. Res. 28:2 (1998), 115–123.
222. Wang, Y., Rosen, H., Madtes, D.K., Shao, B., Martin, T.R., Heinecke, J.W., et al. Myeloperoxidase inactivates TIMP-1 by oxidizing its N-terminal cysteine residue: an oxidative mechanism for regulating proteolysis during inflammation. J. Biol. Chem. 282:44 (2007), 31826–31834.
223. Shirley, R., Ord, E., Work, L., Oxidative stress and the use of anti-oxidants in stroke. Antioxidants 3 (2014), 472–501.